SimpliStor™ Solid State Data Recorder Delivers High-Speed, Radiation-Tolerant Storage for Next-Generation Space Missions
Frontgrade™ Technologies, a leading provider of high-reliability electronic solutions for space and national security missions, today announced the release of the SimpliStor™ Solid State Data Recorder (SSDR), a next-generation, radiation-tolerant data recorder that gives satellite operators, system integrators, and spacecraft designers a faster, smarter, and more resilient way to capture and protect mission-critical information in orbit.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120514203/en/
Frontgrade's SimpiStor™ 2.5TB Solid-State Data Recorder
High-Throughput Performance
SimpliStor delivers 2.5 terabytes of storage and 10Gbps throughput in a compact 3U SpaceVPX package, combining exceptional performance with low power consumption.
Users can record more data in less time, with latency under 100 microseconds and continuous “store-to-full” recording, ensuring no data loss during peak operations. A 33-minute continuous recording window and rapid full-erase cycle (<1 minute) help operators capture complete mission runs, speed up data turnaround, and keep spacecraft in operation longer, increasing overall mission productivity.
Simplifying system design and integration, SimpliStor acts as a Network Attached Storage (NAS) device, it connects easily through a single 10GBase-KR Ethernet link, reducing cabling, complexity, and integration time.
For more advanced applications, its 4-lane PCIe Gen 3.0 interface allows onboard processors to access, analyze, and act on data instantly, enabling AI-driven autonomy, onboard analytics, and compression. Users can gain faster insights in orbit, reduce reliance on limited downlink bandwidth, and lower mission costs through smarter, more autonomous spacecraft operations.
Engineered for Harsh Environments
Designed for extreme environments, SimpliStor withstands 30k–50k rad(Si) unshielded total ionizing dose and is immune to non-destructive single-event latch-up through 37MeV-cm2/mg. SimpliStor operates from –25°C to +65°C while consuming less than 25W dynamic power. It enables high-resolution imagery, continuous payload logging, and real-time onboard analytics for platforms ranging from CubeSats to GEO satellites.
“As missions become increasingly data-driven, our customers need storage systems that are as intelligent and resilient as their spacecraft,” said Lorne Graves, Sr. VP and Chief Technology Officer, Frontgrade Technologies. “SimpliStor empowers them to collect, process, and protect critical information faster and more efficiently, turning raw data into actionable insight that drives mission success.”
Frontgrade’s long-standing reputation in high-reliability electronics ensures that SimpliStor meets the highest standards for performance, longevity, and mission assurance. By combining power efficiency, system flexibility, and radiation-tolerant reliability, Frontgrade continues to reduce customer risk, shorten development timelines, and enhance operational confidence for the next generation of space missions. Learn more about SimpliStor.
About Frontgrade™
Frontgrade Technologies builds mission-critical electronics and electromechanical products for space, aerospace, and defense. With over 60 years of space flight heritage, the portfolio includes high-reliability components, subsystems, and assemblies engineered for performance and built for speed. Proven in operation, these technologies support complex missions across air, land, sea, space, and cyber, and perform reliably in the world’s most demanding environments. From RF and microwave technologies to motion control, power, and processing, Frontgrade delivers the innovation, precision, and execution today’s missions demand. Learn more at www.frontgrade.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251120514203/en/
Contacts
For Media Inquiries Contact
Sharon Harnisch, MarCom Manager
Frontgrade Technologies
+1.719.487.4259
Sharon.Harnisch@Frontgrade.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
“ All Genetic Diseases Could be Cured within a Decade ” , Hears Dubai Future Forum20.11.2025 15:15:00 EET | Press release
All known genetic diseases could be cured within the next decade thanks to major advances in gene editing, a leading scientist told the Dubai Future Forum 2025. Discussing his company’s research, Dr. Trevor Martin, Co-founder and CEO of Mammoth Biosciences, described “a one-time cure that will reshape the healthcare system as we know it.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120548681/en/ Dubai Future Forum 2025 (Photo: AETOSWire) Opening the forum, Khalfan Belhoul, CEO of Dubai Future Foundation, introduced the concept of “national cognitive potential”, arguing that countries in the future will gain a competitive edge in fields like AI by leveraging the collective cognitive strength of their societies. In another session, Dr. Nikku Madhusudhan, Professor of Astrophysics at the University of Cambridge, said there is a “good chance” humanity will discover life on another planet—possibly in the next decade. He exp
Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies20.11.2025 15:00:00 EET | Press release
Cassidy Bio, a biotechnology company developing the first AI-driven genomic foundation model to enhance the design of gene editing therapies, today announced its launch and the closing of an $8 million seed financing round. The company will use the funding to advance its platform, built as a holistic solution designed to bring precision, speed, and clinical confidence to the rapidly growing field of gene therapies. Cassidy Bio’s AI-driven genomic foundation model combines proprietary wet-lab data, population-scale genomic insights, and advanced machine learning to predict the best pairings of guides, enzymes, and delivery modalities, matching them to optimal therapeutic contexts. This creates a scalable capability that supports an end-to-end workflow for genome editing at scale. By moving from siloed trial-and-error to a holistic, predictive approach, Cassidy aims to accelerate the discovery and development of safer, more reliable genetic medicines. “The promise of genome editing will
12 Major Verification Trends in 2026: Regula on the Birth of a New Digital Identity20.11.2025 15:00:00 EET | Press release
How we verify is changing — and so is who and what we verify. Are we dealing with real people, fraudsters, or machines acting on their behalf? A new Regula report on 12 identity verification trendsexamines how these shifts are forcing businesses to rebuild their verification processes to stay ahead of fraud, comply with regulations, and regain eroding customer confidence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120373343/en/ Identity is leaving the human domain: Regula’s forecast illustrates the emerging need to verify systems, autonomous agents, and machine customers. The new face of fraud The identity threat landscape has entered a new industrial phase, defined by three structural shifts: Machine identity. Identity verification (IDV) is no longer limited to people. It now extends to autonomous systems acting on their behalf — AI agents that can open accounts, submit documents, and bypass checks on their own. Frau
Scientist.com Completes Acquisition by GHO Capital Partners to Accelerate Global R&D Orchestration20.11.2025 14:55:00 EET | Press release
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform, and GHO Capital Partners LLP (“GHO”), the specialist private equity investor in global healthcare, today announced the successful closing of GHO’s acquisition of Scientist.com. The transaction marks the beginning of an accelerated expansion phase, strengthening Scientist.com’s mission to transform pharmaceutical R&D by streamlining the entire outsourced research lifecycle. “This is a pivotal moment for Scientist.com and for the global research community we support,” said Kevin Lustig, CEO and Chris Petersen, CTO, the founders of Scientist.com. “Partnering with GHO, a team that shares our vision and brings deep expertise in scaling healthcare technology companies, enables us to invest aggressively in our AI-powered orchestration platform and expand our global footprint. Together, we are better positioned than ever to meet growing demand for faster, smarter and more compliant research sourcing.” Fo
Compass Pathways to Participate in Two Investor Conferences in December20.11.2025 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following December investor conferences: 8th Annual Evercore Healthcare Conference – Coral Gables, FL: Fireside chat at 10:00am ET on December 2, 2025 Piper Sandler 37th Annual Healthcare Conference – New York, NY: Fireside chat at 1:30pm ET on December 3, 2025 A live audio webcast of these events will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatment
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom